Nexalin Technology Inc

Research Nexalin Technology Inc (NXL) on Bullrun: market cap USD 6.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 6.57M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 301.65K-USD 8.22M-USD 5.05M79.7%-0.5USD 654.78Kn/aUSD 3.75M
FY2024USD 168.72K-USD 7.61M-USD 4.11M78.3%-0.83USD 574.49KUSD 0USD 3.68M
FY2023USD 110.75K-USD 4.65Mn/a76.8%-0.63USD 580.23KUSD 4.46KUSD 3.21M
FY2022USD 1.32M-USD 1.70Mn/a72.5%-0.3USD 162.74KUSD 806.04KUSD 5.48M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 6.57Mn/an/an/a
20252025-12-31USD 10.74Mn/an/an/a
20242024-12-31USD 36.72Mn/an/an/a
20232023-12-29USD 3.05Mn/an/an/a
20222022-12-30USD 5.46Mn/an/an/a

About Nexalin Technology Inc

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Nexalin Technology Inc's market cap?

Nexalin Technology Inc's market capitalization is USD 6.57M.

What does Nexalin Technology Inc do?

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China.